The U.S. House’s vote to remove Rep. Kevin McCarthy (R-Calif.) from the speakership has paused action on multiple bills with [...] …
Category: Regulatory
Medicare drug price negotiations will move ahead as planned after major drugmakers agreed to participate and a federal district judge [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The two hospital systems subject to a senator’s investigation into 340B program revenue have said they are fully compliant with [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The final rule to provide repayment to many 340B hospitals for five years of unlawful Medicare cuts entered the final [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A national hospital group has asked a federal district court for permission “to correct numerous misstatements” that it says drug [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The top Republican on an influential Senate committee has opened an investigation into how two major health systems use revenue [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The government agency that oversees the 340B program will retain just over half of its staff in the event of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug purchases under the 340B program totaled $53.7 billion in 2022, or 22.3% more than the $43.9 billion in 2021, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Amid an increasing number of drugmaker restrictions and requirements on the use of contract pharmacies, 340B providers are trying a [...] …